Ibrance 125 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q4V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,555
Award facts
- Contract value 100% obligated
- $8,555.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg tablets (7-count) under a firm fixed-price contract with a ceiling value of $8,555.21. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by January 23, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a prime contract value of $999,999,999.00 through December 2026.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications to military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill comprehensive pharmaceutical supply requirements across multiple therapeutic domains. This delivery order for Ibrance—a brand-name oncology medication—reflects the company's role in supporting Defense Health Agency and other federal healthcare systems with specialty pharmaceutical products. The competitively awarded contract reinforces AmerisourceBergen's position as a primary vendor for federal medical supply needs within the DLA's pharmaceutical support infrastructure.
Quick answers
Who was awarded contract SPE2DR26F9Q4V?
SPE2DR26F9Q4V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F9Q4V worth?
The government has obligated $8,555 on SPE2DR26F9Q4V.
Is contract SPE2DR26F9Q4V an order under another contract?
Yes. SPE2DR26F9Q4V is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q4V competed?
The extent of competition for SPE2DR26F9Q4V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award